Core Viewpoint - As of August 8, 2025, the number of A-share shareholders for the company is reported to be 25,725 [1] Company Summary - The company, Andon Health A (000553), provided an update on its A-share shareholder count in response to investor inquiries on August 18 [1]

证券代码：000553(200553) 证券简称：安道麦 A(B) 公告编号：2025-26 号 安道麦股份有限公司 关于举办 2025 年半年度网上业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、 说明会召开方式及时间 安道麦股份有限公司（以下简称"公司"）2025 年半年度报告在深圳证券交 易所网站（www.szse.cn）及指定媒体的披露日为 2025 年 8 月 27 日。 为了让广大投资者进一步了解公司 2025 年第二季度和上半年的经营情况， 公司将于 2025 年 8 月 27 日（星期三）下午 3:00-4:00 举行 2025 年半年度网上业 绩说明会。 二、 会议语言 公司总裁兼首席执行官 Gaël Hili 先生、首席财务官 Efrat Nagar 女士、首席 商务官 Eric Dereudre 先生、全球投资者关系负责人 Joshua Phillipson 先生和董事 会秘书郭治先生将参加说明会。 四、 投资者参会方式 本次网上业绩路演将在同花顺路演平台和智通财经"大路演"同时直播，欢 迎广大投资者通过下述方式收看 ...

Core Viewpoint - The company, Ando Amway A (000553.SZ), has confirmed that its innovative compound GilboaTM (flumetylsulforim) is classified as an innovative agricultural drug, featuring a new mechanism of action for grain fungicides [2] Group 1 - The innovative compound GilboaTM has been certified by the Fungicide Resistance Action Committee, indicating its novel mechanism for controlling grain diseases [2]

Core Viewpoint - The implementation of the "One Product, One Certificate" policy starting January 1, 2026, is expected to significantly impact the pesticide industry, leading to the exit of 80% of borrowing certificate-produced pesticides from the market, which will force many large distributors to shift towards purchasing pesticide formulations from leading companies [1] Group 1 - The Ministry of Agriculture and Rural Affairs issued Announcement No. 925 on June 29, 2025, to regulate pesticide labeling and instruction management, which will take effect on January 1, 2026 [1] - The announcement aims to further standardize pesticide labeling, promoting fair competition within the pesticide market [1] - As a leading global plant protection enterprise, the company possesses a substantial reserve of registration certificates and is committed to responding positively to government requirements for the sustainable development of the pesticide industry [1]

Core Viewpoint - The performance of pesticide companies in the first half of the year shows significant disparities, with some companies experiencing substantial profit growth while others face losses due to varying product prices and market conditions [2][4]. Group 1: Company Performance - Limin Co., Ltd. reported a net profit increase of 747.13% in the first half of the year, achieving a revenue of 2.69 billion yuan, driven by rising prices of its main products [3][4]. - Xinda Co., Ltd. expects a net profit increase of 2443.43% to 2834.73%, primarily due to the price surge of its main product, oxazolone [4]. - Ando Agricultural Co. anticipates a loss of 54 million to 108 million yuan, citing "price weakness" as a key factor [4]. - Hongtaiyang expects a loss of 168 million to 228 million yuan, attributing the downturn to intense market competition and low product prices [4][5]. Group 2: Market Trends - The pesticide industry is experiencing a recovery, but the price of formulation products remains weak overall [2][6]. - The price of the key product, mancozeb, increased from 23,500 yuan per ton in March to 25,000 yuan per ton by mid-year, reflecting a 6.4% rise [6]. - The price of abamectin rose from 350,000 yuan per ton at the beginning of the year to 510,000 yuan per ton by June [6]. - The overall pesticide price index (CAPI) was 79.48 in June, showing a slight increase of 0.47% month-on-month but a year-on-year decrease of 3.77% [8]. Group 3: Industry Insights - The growth of Limin Co. is not representative of the entire pesticide industry, as it benefits from specific advantages [9]. - The industry is undergoing a restructuring of supply dynamics, with expectations of a more equitable competitive environment in the next three years, which may lead to improved product prices and profitability [9].

Group 1 - The company's financial performance objectively and truthfully reflects the industry market environment and the results of its operations [1]

Core Viewpoint - The company, Andermatt A (000553.SZ), confirmed that its main business focuses on crop protection products and does not involve any antibiotic-related business [2] Company Summary - Andermatt A's primary business is in crop protection products [2] - The company does not engage in the antibiotic sector [2]

Group 1 - The company currently focuses on agricultural planting applications for its pesticide formulation products in the domestic market [1] - An investor inquired about the company's production of mosquito control products [2]

特别提示： 登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 二、判决情况 2025年8月4日，武汉中院就本次诉讼作出一审判决，武汉中院经审理认为，原告的诉讼请求缺乏事实和 法律依据，诉讼请求不能成立，判决驳回原告的诉讼请求，案件受理费由原告负担。 三、其他尚未披露的诉讼仲裁事项 1.案件所处的诉讼阶段：湖北省武汉市中级人民法院（以下简称"武汉中院"）作出一审判决。 2.上市公司所处的当事人地位：安道麦股份有限公司（以下简称"公司"或"安道麦"）为被告之一。 3.涉案的金额：原告请求三被告（中国化工集团有限公司、先正达集团股份有限公司及安道麦股份有限 公司）共同承担原告的投资损失人民币916,135元以及诉讼费用。 4.对上市公司损益产生的影响：武汉中院判决驳回原告的诉讼请求，并判令原告承担案件受理费。判决 结果不会对公司本期利润或期后利润产生影响。 一、本次诉讼事项的基本情况 2025年2月，一名自然人（以下简称"原告"）以证券虚假陈述责任为由对中国化工集团有限公司（被告 一）、先正达集团股份有限公司（被告二） ...

证券代码： 000553(200553) 证券简称: 安道麦 A(B) 公告编号: 2025-25 号 安道麦股份有限公司 关于自愿披露公司涉及诉讼的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1.案件所处的诉讼阶段：湖北省武汉市中级人民法院（以下简称"武汉中院"） 作出一审判决。 2.上市公司所处的当事人地位：安道麦股份有限公司（以下简称"公司"或"安 道麦"）为被告之一。 3.涉案的金额：原告请求三被告（中国化工集团有限公司、先正达集团股份 有限公司及安道麦股份有限公司）共同承担原告的投资损失人民币 916,135 元以 及诉讼费用。 4.对上市公司损益产生的影响：武汉中院判决驳回原告的诉讼请求，并判令 原告承担案件受理费。判决结果不会对公司本期利润或期后利润产生影响。 截至本公告披露日，公司及控股公司不存在其他应披露而未披露的诉讼、仲 裁事项。 四、本次诉讼对公司本期利润或期后利润的可能影响 武汉中院判决驳回原告的诉讼请求，并判令原告承担本次诉讼的案件受理费。 本次诉讼的判决结果不会对公司本期利润或期后利润产生影响。公司将密切关 ...